FDA Adverse Event Injury Summary report: N

ACRYSOF MULTIPIECE IOL

MDR report key: 10085165 · Received May 25, 2020

Report

Report Number
1119421-2020-00793
Event Type
Injury
Date Received
May 25, 2020
Report Date
May 25, 2020
Manufacturer
ALCON RESEARCH, LLC - HUNTINGTON
Product Code
HQL
PMA / PMN Number
P930014
Removal / Correction Number
NA
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE PRODUCT WAS NOT RETURNED FOR ANALYSIS. COMPLAINT HISTORY AND PRODUCT HISTORY RECORDS COULD NOT BE REVIEWED BECAUSE THE REPORT DID NOT PROVIDE A LOT NUMBER OR ANY IDENTIFICATION TRACEABLE TO THE MANUFACTURING DOCUMENTATION. THE DIRECTIONS FOR USE STATE THIS MODEL LENS IS INTENDED FOR PLACEMENT IN THE CAPSULAR BAG. THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4).

Description of Event or Problem · 1

A PHYSICIAN REPORTED IN A LITERATURE ARTICLE TITLED, CLINICAL OUTCOMES AND INTRAOCULAR PRESSURE (IOL) CONTROL AFTER SCLERAL-GLUED INTRAOCULAR LENS (IOL) INSERTION IN EYES WITH PSEUDOEXFOLIATION (PXF), THAT THE SCLERAL GLUED SURGERY IS A GOOD OPTION FOR FIXATING AN IOL IN EYES WITH PXF AND POOR ZONULAR INTEGRITY OR ABSENT CAPSULAR SUPPORT. SPECIAL ATTENTION SHOULD BE PLACED ON IOP CONTROL FOLLOWING SURGERY. THIS REPORT IS REGARDING ONE OF THREE EYES WHICH WERE COMPLICATED BY OPTIC CAPTURE, ALL OF WHICH INVOLVED ONE MODEL SCLERAL-GLUED IOL. THIS CASE WAS COMPLICATED BY RECURRENT EPISODES OF OPTIC CAPTURE STARTING AT POSTOPERATIVE MONTH ONE AND INITIALLY MANAGED WITH PUPILLARY DILATION AND ND:YAG PERIPHERAL IRIDOTOMY, BUT EVENTUALLY REQUIRED A SURGICAL PUPILLOPLASTY AT POSTOPERATIVE MONTH FOURTEEN. THERE ARE THREE MEDICAL DEVICE REPORTS ASSOCIATED WITH OPTIC CAPTURE IN THIS ARTICLE. THIS REPORT IS ASSOCIATED WITH THE SECOND EYE WITH OPTIC CAPTURE REPORTED IN THE ARTICLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
548645 ACRYSOF MULTIPIECE IOL INTRAOCULAR LENS HQL ALCON RESEARCH, LLC - HUNTINGTON MA60AC ASKU

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention